美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=VYVANSE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
VYVANSE 021977 001 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 30MG Yes No 2007/02/23 2007/02/23 SHIRE DEVELOPMENT Prescription
VYVANSE 021977 002 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 50MG Yes No 2007/02/23 2007/02/23 SHIRE DEVELOPMENT Prescription
VYVANSE 021977 003 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 70MG Yes Yes 2007/02/23 2007/02/23 SHIRE DEVELOPMENT Prescription
VYVANSE 021977 004 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 20MG Yes No 2007/02/23 2007/12/10 SHIRE DEVELOPMENT Prescription
VYVANSE 021977 005 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 40MG Yes No 2007/02/23 2007/12/10 SHIRE DEVELOPMENT Prescription
VYVANSE 021977 006 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 60MG Yes No 2007/02/23 2007/12/10 SHIRE DEVELOPMENT Prescription
VYVANSE 021977 007 NDA LISDEXAMFETAMINE DIMESYLATE CAPSULE;ORAL 10MG Yes No 2007/02/23 2014/10/30 SHIRE DEVELOPMENT Prescription
VYVANSE 208510 001 NDA LISDEXAMFETAMINE DIMESYLATE TABLET, CHEWABLE;ORAL 10MG Yes No 2017/01/28 2017/01/28 SHIRE DEV LLC Prescription
VYVANSE 208510 002 NDA LISDEXAMFETAMINE DIMESYLATE TABLET, CHEWABLE;ORAL 20MG Yes No 2017/01/28 2017/01/28 SHIRE DEV LLC Prescription
VYVANSE 208510 003 NDA LISDEXAMFETAMINE DIMESYLATE TABLET, CHEWABLE;ORAL 30MG Yes No 2017/01/28 2017/01/28 SHIRE DEV LLC Prescription
VYVANSE 208510 004 NDA LISDEXAMFETAMINE DIMESYLATE TABLET, CHEWABLE;ORAL 40MG Yes No 2017/01/28 2017/01/28 SHIRE DEV LLC Prescription
VYVANSE 208510 005 NDA LISDEXAMFETAMINE DIMESYLATE TABLET, CHEWABLE;ORAL 50MG Yes No 2017/01/28 2017/01/28 SHIRE DEV LLC Prescription
VYVANSE 208510 006 NDA LISDEXAMFETAMINE DIMESYLATE TABLET, CHEWABLE;ORAL 60MG Yes Yes 2017/01/28 2017/01/28 SHIRE DEV LLC Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database